Can NSIP Go Into Remission or Relapse? What to Know

Yes, non-specific interstitial pneumonia (NSIP) can stabilize and become “quiet” with treatment, but it is also possible for the disease to relapse or progress ^[1]. Clinicians more often describe this quiet state as “long-term control” or “stability” rather than a true remission, because any existing lung scarring (fibrosis) typically does not reverse, and the risk of future flare-ups remains. Because of this, NSIP management involves ongoing monitoring and highly individualized treatment.

Improvement and Stability

Many people with NSIP see substantial improvement with initial immunosuppressive treatment ^[2][3]. Because NSIP is a lung-pattern diagnosis that can be idiopathic (unknown cause) or linked to underlying connective tissue diseases or certain medications, identifying the specific cause helps doctors tailor your prognosis and treatment ^[4]. Stability is particularly common for patients who have an underlying connective tissue disease or whose NSIP is predominantly cellular (meaning it involves active inflammation rather than mostly established scarring) ^[4][5]. Treatment with corticosteroids (such as prednisone) often reduces this inflammation, leading to stabilized or improved lung function and breathing symptoms ^[6][3].

Relapse vs. Progression

Even after a favorable initial response, NSIP can worsen again ^[7]. Doctors distinguish between two types of worsening:

• Relapse: The return of active inflammation and symptoms after a period of stability, often occurring during or after the reduction of medications ^[2].
• Progression: A broader term used when the disease continues to worsen over time. Clinicians assess progression based on a combination of worsening symptoms, declining lung function, increasing oxygen needs, and new physical scarring on imaging ^[8][9]. People whose NSIP is predominantly fibrotic (scarring) or mixed are generally at a higher risk for ongoing progression than those with purely cellular disease ^[9][5].

Medication Tapering and Maintenance Therapy

Systemic corticosteroids carry significant side effects, so doctors usually try to slowly lower (taper) the dose once the disease is stable ^[10]. There is no universal tapering schedule; it is customized based on your lung response, underlying conditions, and side effects ^[10].
Important Safety Note: Never reduce or stop your corticosteroid or immunosuppressant medication on your own. Abruptly stopping can cause a dangerous condition called adrenal insufficiency and may trigger a severe disease flare.

To help lower the steroid dose while trying to prevent a relapse, your doctor may prescribe a maintenance therapy (often called a “steroid-sparing” drug, because it helps control inflammation while allowing you to lower the steroid dose and reduce steroid side effects), such as mycophenolate mofetil or azathioprine ^[11][12]. While observational studies suggest these medications may help stabilize lung function in some patients, they are not guaranteed to prevent progression ^[1][13]. Because these drugs suppress your immune system, they require routine blood tests to monitor your liver, kidneys, and blood counts, and they increase your risk of infections ^[14]. Discuss infection prevention, including vaccines, with your care team.

Surveillance: Monitoring Your Lungs

Because relapse and progression are possible, long-term surveillance is necessary. The frequency of visits will be tailored to you—often closer together during a medication taper or after a treatment change. Your care team uses several tools:

• Pulmonary Function Tests (PFTs): Routine breathing tests measure Forced Vital Capacity (FVC) and Diffusing Capacity for Carbon Monoxide (DLCO). DLCO estimates the lungs’ ability to transfer gas into the blood; because an isolated change in DLCO can be caused by factors other than NSIP, doctors interpret trends alongside your FVC, symptoms, and other clinical findings ^[1][15].
• Oxygen and Exercise Testing: A 6-minute walk test to monitor your oxygen saturation (SpO2) and exercise capacity helps doctors track how the disease affects your daily function ^[16][17].
• Repeat Imaging (HRCT): High-resolution CT scans are not routinely done on a fixed schedule for stable NSIP. Instead, doctors order them when symptoms worsen or PFTs decline, to evaluate physical changes in the lungs ^[8][18].

Monitoring your disease can be emotionally taxing. It is important to remember that not every minor daily fluctuation in your cough, fatigue, or home oxygen reading means your disease is progressing, though persistent or sudden changes always warrant a medical evaluation.

Is It a Relapse, or Something Else?

If your breathing suddenly worsens, doctors will not automatically assume it is an NSIP relapse. Acute deterioration requires a careful medical evaluation to distinguish a true relapse from:

• Infections: Opportunistic infections (like Pneumocystis jirovecii) or typical viral and bacterial pneumonias are serious risks when taking immunosuppressants and can mimic a relapse ^[14][19]. Note that your medications might suppress a fever, so you cannot rely on the absence of fever to rule out an infection.
• Drug Toxicity: Some medications can cause lung inflammation as a side effect, looking similar to NSIP on a CT scan ^[20][21].
• Other Medical Events: Conditions like a pulmonary embolism (blood clots in the lungs), heart failure, or fluid overload can cause sudden shortness of breath ^[19][22].
• Deconditioning: A gradual loss of physical fitness due to inactivity can make breathing feel harder during exertion, even if the lungs themselves are physically stable ^[17].

URGENT WARNING SIGNS: Do not wait for a clinic appointment if you experience severe or rapidly worsening shortness of breath, chest pain, fainting, confusion, blue lips, or a markedly lower oxygen level than your doctor’s advised threshold. Call emergency services immediately.